Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil

American Journal of Tropical Medicine and Hygiene

Volumn 57, Issue 2, 1997, Pages 142-148

  Segurado, Aluisio A C ^a   Malaque, Ceila M S ^a   Sumita, Laura M ^a   Pannuti, Claudio S ^a   Lal, Renu B ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; VIRUS DNA;

ARTICLE; BLOOD DONOR; BRAZIL; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MONONUCLEAR CELL; PATIENT COUNSELING; POLYMERASE CHAIN REACTION; SEROPREVALENCE; VIRUS ISOLATION;

DNA VIRUSES; HTLV; HTLV 1; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 0030876939     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1997.57.142     Document Type: Article

References (45)

1. Blattner WA, 1990. Epidemiology of HTLV-I and associated diseases. Blattner WA, ed. Human Retrovirology: HTLV. New York: Raven Press, 251-265.
2. Takatsuki K, Yamaguchi K, Kawano F, Hattori T, Nishimura H, Tsuda H, Sanada I, Nakada K, Itai Y, 1985. Clinical diversity in adult T-cell leukemia lymphoma. Cancer Res 45 (suppl): 4644-4645.
3. Osame M, Usuku K, Izumo S, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M, 1986. HTLV-I associated myelopathy, a new clinical entity. Lancet i: 1031-1032.
4. Heneine W, Kaplan J, Gracia F, Lal RB, Roberts B, Levine PH, Reeves WC, 1991. HTLV-II endemicity among Guaymi Indians in Panama (letter). N Egl J Med 324: 565.
5. Maloney EM, Biggar RJ, Neel JV, Taylor ME, Hahn BH, Shaw GM, Blattner WA, 1992. Endemic Human T-cell lymphotropic virus type II infection among isolated Brazilian Amerindians. J Infect Dis 166: 100-107.
6. Levine PH, Jacobson S, Elliott R, Cavallero A, Colclough G, Dorry C, Stephenson C, Knigge RM, Drummond J, Nishimura M, Taylor ME, Wiktor S, Shaw GM, 1993. HTLV-II infection in Florida Indians. AIDS Res Hum Retroviruses 9: 123-127.
7. Khabbaz RF, Onorato IM, Cannon RO, Hartley TM, Roberts B, Hosein B, Kaplan JE. 1992. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually-transmitted diseases. N Engl J Med 326: 375-380.
8. Zella D, Mori L, Sala M, Ferrante P, Gasoli G, Magnani G, Achilli G, Cattaneo E, Lori F, Bertazzoni U, 1990. HTLV-II infection in Italian drug abusers. Lancet 336: 575-576.
9. Kalyanaraman S, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Blayney D, Golde D, Gallo RC, 1982. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 218: 571-573.
10. Loughran TP Jr, Coyle T, Sherman MP, Starkenbaum G, Ehrlich GD, Ruscetti FW, Poiesz BJ, 1992. Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. Blood 80: 1116-1119.
11. Harrington WJ Jr, Sheremata W, Hjelle B, Dube DK, Bradshaw P, Foung SKH, Snodgrass S, Toedter S, Cabrai L, Poiesz B, 1993. Spastic ataxia associated with human T-cell lymphotropic virus type II infection. Ann Neurol 33: 411-414.
12. Jacobson S, Lehky T, Nishimura M, Robinson S, McFarlin DE, Dhib-Jalbut S, 1993. Isolation of HTLV-2 from a patient with chronic progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol 33: 392-396.
13. Saji F, Ohashi K, Tokugawa Y, Kamiura S, Azuma C, Tanizawa O, 1990. Perinatal infection of human T-lymphotropic virus type I, the etiologic virus of ATL/L. DNA amplification of specific HTLV-I sequences. Cancer 66: 1933-1937.
14. Lal RB, Owen SM, Segurado AAC, Gongora-Bianchi RA, 1994. Mother-to-child transmission of human T-lymphotropic virus type II (HTLV-II). Ann Intern Med 120: 300-301.
15. Sullivan MT, Williams AE, Fang CT, Grandinetti T, Poiesz BJ, Ehrlich GD, 1991. Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of blood recipients (1983 through 1988). Arch Intern Med 151: 2043-2048.
16. Hjelle B, Mills R, Mertz G, Swenson S, 1990. Transmission of HTLV-II via blood transfusion. Vox Sang 59: 119-122.
17. Rosenblatt JD, Plaeger-Marshail S, Giorgi JV, Swanson P, Chen ISY, Chin E, Wang HJ, Canavaggio M, Black AC, Lee H, 1990. A clinical, hematologic and immunologic analysis of 21 HTLV-II-infected intravenous drug users. Blood 76: 409-417.
18. Ehrlich GD, Glaser JB, La Vigne K, Quan D, Mildvan D, Sninsky JJ, Kwok S, Papsidero L, Poiesz BJ, 1989. Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction. Blood 74: 658-664.
19. Murphy EL, Figueroa JP, Gibbs WN, Brathwaite A, Holding-Cobham M, Waters D, Cranston B, Hanchard B, Blattner WA, 1989. Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 111: 555-560.
20. Gracia F, 1992. HTLV-II among Guaymi Indians - Panama. JAMA 267: 2163-2164.
21. Cortes E, Detels R, Aboulafia D, Li XL, Moudgil T, Alam M, Bonecker C, Gonzaga A, Oyafuso L, Tondo M, Boite C, Hammershlak N, Capitani C, Slamon DJ, Ho DD, 1989. HIV-I, HIV-II and HTLV-I infection in high-risk groups in Brazil. N Engl J Med 320: 953-958.
22. Oliveira MSP, Matutes E, Famadas LC, Schulz TF, Calabro ML, Nucci M, Andrada-Serpa MJ, Tedder RS, Weiss RA, Catovsky D, 1990. Adult T-cell leukemia/lymphoma in Brazil and its relation to HTLV-I. Lancet 336: 987-990.
23. Castro LHM, Chaves CJ, Callegaro D, Nobrega JPS, Scaff M, 1989. HTLV-I associated myelopathy in Brazil. Arq Neuropsiquiatr 47: 501-502.
24. Spina-Franca A, Livramento JA, Machado LR, Gomes HR, Vianna LS, Castro LHM, Nobrega JPS, Bacheschi LA, 1990. HTLV-I antibodies in serum and cerebrospinal fluid in tropical spastic paraparesis in Brazil. Arq Neuropsiquiatr 48: 441-447.
25. Centers for Disease Control and the U.S.RH.S Working Group, 1993. Guidelines for counseling persons infected with human T-lymphotropic virus type I (HTLV-I) and type II (HTLV-2). Ann Intern Med 118: 448-454.
26. Lal RB, 1996. Delineation of immunodominant epitopes of human T-lymphotropic virus types I and II and their usefulness in developing serologic assays for detection of antibodies to HTLV-I and HTLV-II. J Acquir Immune Defic Syndr Hum Retrovirol 13: S170-S178.
27. Varma M, Rudolph DL, Knuchel M, Switzer W, Hadlock KG, Velligan M, Chan L, Foung SKH, Lal RB, 1995. Enhanced specificity of truncated transmembrane protein for serologic confirmation of HTLV-I and HTLV-II infection by Western blot (immunoblot) assay containing recombinant envelope glycoproteins. J Clin Microbiol 33: 3239-3244.
28. Heneine W, Khabbaz RF, Lal RB, Kaplan JE, 1992. Sensitive and specific polymerase chain reaction assays for diagnosis of HTLV-I and HTLV-II infections in HTLV-I/II seropositive individuals. J Clin Microbiol 30: 1605-1607.
29. Tuke PW, Luton P, Garson JA, 1992. Differential diagnosis of HTLV-I and HTLV-II infections by restriction enzyme analysis of "nested" PCR products. J Virol Methods 40: 163-174.
30. Kitamura K, Rudolph DL, Goldsmith C, Folks TM, Lal RB, 1993. Isolation, characterization and transmission of human T-lymphotropic virus types I and II in culture. Curr Microbiol 27: 355-360.
31. Toedter G, Pearlman S, Hofheinz D, Blakeslee J, Cockerell G, Dezzutti C, Yee J, Lal RB, Lairmore MD, 1992. Development of a monoclonal antibody-based p24 capsid antigen detection assay for HTLV-I, HTLV-II and STLV-I infections. AIDS Res Hum Retroviruses 8: 527-532.
32. Williams AE, Fang CT, Slamon DJ, Poiesz BJ, Sandler SG, Darr II WF, Shulman G, McGowan EI, Douglas DK, Bowman RJ, Peetoom F, Kleinman SH, Lenes B, Dodd RY, 1988. Seroprevalence and epidemiological correlates of HTLV-I infection in U.S. blood donors. Science 240: 643-646.
33. Lee H, Anderson E, Allain JP, Gonzaga A, 1989. HTLV-I infection in Brazil. Blood 73: 1742-1746.
34. Ferreira OC Jr, Vaz RS, Carvalho MB, Guerra C, Fabron AL, Rosemblit J, Hamerschlak N, 1995. Human T-lymphotropic virus type I and type II infections and correlation with risk factors in blood donors from Sao Paulo, Brazil. Transfusion 35: 258-263.
35. Pombo de Oliveira MS, Hamerschlak N, Chiattone C, Loureiro P, 1996. HTLV-I infection and adult T-cell leukemia in Brazil: an overview. S Paulo Med J 114: 1117-1185.
36. Moreira ED Jr, Ribeiro TT, Swanson P, Sampaio Filho C, Melo A, Brites C, Badari R, Toedter G, Lee H, Harrington W Jr, 1993. Seroepidemiology of human T-cell lymphotropic virus type I/II in Northeastern Brazil. J Acquir Immune Defic Syndr 6: 959-963.
37. Gabbai AA, Bordin JO, Vieira-Filho JPB, Kuroda A, Oliveira ASB, Cruz MV, Ribeiro AAF, Delaney SR, Henrard DR, Rosario J, Roman GC, 1993. Selectivity of human T lymphotropic virus type-1 (HTLV-I) and HTLV-2 infection among different populations in Brazil. Am J Trop Med Hyg 49: 664-671.
38. Wattel E, Mariotti M, Agis F, Gordien E, Prou O, Courouce AM, Rouger P, Wain-Hobson S, Chen ISY, Leftere JJ, 1992. Human T lymphotropic virus (HTLV) type I and II DNA amplification in HTLV-I/II-seropositive blood donors of the French West Indies. J Infect Dis 165: 369-372.
39. Morofuji-Hirata M, Kajiyama W, Nakashima K, Noguchi A, Hayashi J, Kashiwagi S, 1993. Prevalence of antibody to human T-cell lymphotropic virus type I in Okinawa, Japan, after an interval of 9 years. Am J Epidemiol 137: 43-48.
40. Lee HH, Swanson P, Rosenblatt JD, Chen ISY, Sherwood WC, Smith DE, Tegtmeier GE, Fernando IP, Fang CT, Osame M, Kleinman SH, 1991. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in U S. blood donors. Lancet 337: 1435-1439.
41. Lipka JJ, Young KKY, Kwok SY, Reyes GR, Sninsky JJ, Foung SKH, 1991. Significance of human T-lymphotropic virus type I indeterminant serological findings among healthy individuals. Vox Sang 61: 171-176.
42. Khabbaz RF, Heneine W, Grindon A, Hartley TM, Schulman G, Kaplan JE, 1992. Indeterminate HTLV serologic results in U.S blood donors: are they due to HTLV-I or HTLV-II?. J Acquir Immune Defic Syndr 5: 400-404.
43. Banki K, Maceda J, Hurley E, Ablonczy E, Mattson DH, Szegedy L, Hung C, Peri A, 1992. Human T-cell lymphotropic virus (HTLV)-related endogenous sequence, HRES-1, encodes a 28-kDa protein: a possible autoantigen for HTLV-I-gag-reactive antibodies. Proc Natl Acad Sci USA 89: 1939-1943.
44. Miyakoshi H, Sugimoto M, Igarashi H, Honda H, Fujino R, Mizukoshi M, 1992. Improvement of simultaneous detection of antibodies to gag and envelope antigens of human T-lymphotropic virus type I by Western immunoblot assay. J Clin Microbiol 30: 2555-2559.
45. Dezzutti CS, Rudolph DL, Roberts CR, Lal RB, 1993. Characteristics of human T-lymphotropic virus type I-and II-infected T cell lines: antigenic, phenotypic and genotypic analysis. Virus Res 29: 59-70.